[ad_1] A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing. [ad_2] Source link
Tag: Legend Biotech
E Fund Management Hong Kong Co. Ltd. Has $2.65 Million Stock Holdings in Legend Biotech Co. (NASDAQ:LEGN)
[ad_1] E Fund Management Hong Kong Co. Ltd. raised its stake in shares of Legend Biotech Co. (NASDAQ:LEGN – Get Rating) by 66.2% during the 1st quarter, according to the…